Generally agreed-upon indications for platelet-lowering therapy include Cardiovascular risk factors Transient ischemic attacks Tobacco use Significant bleeding Need for a surgical procedure in patients with extreme thrombocytosis and low ristocetin cofactor activity Sometimes severe migraine However, there are no data that prove cytotoxic therapy to reduce the platelet count lowers thrombotic risk or improves survival.